Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia

David M. Ross Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, SA, 5000, AustraliaCorrespondence[email protected]

Sharon R. Jackson Department of Haematology, Middlemore Hospital, Auckland, New Zealand

Peter J. Browett Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand

Click to increase image sizeClick to decrease image size

Notes

*A brief summary of this case was previously published in Ross et al. Citation[12] where it was included in a large series comparing quantitative PCR with cytogenetic monitoring of CML.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia

Information for

Open access

Opportunities

Help and information

Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia

Notes

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature